Skip to main content
Gabriel Brooks, MD, Cardiology, San Francisco, CA

GabrielCBrooksMDMAS FACC

Cardiology San Francisco, CA

Non-Invasive Cardiology

Executive Director, Head of Rare Cardiology, Rare Disease Research Unit, Pfizer Inc.

Dr. Brooks is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Brooks' full profile

Already have an account?

  • Office

    130 Lawton ST
    San Francisco, CA 94122
    Phone+1 510-603-9193

Education & Training

  • University of California
    University of CaliforniaMAS, Clinical Research (Epi/Bio-Stats), 2013 - 2015
  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Cardiovascular Disease, 2011 - 2014
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2008 - 2011
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 2008
  • Carnegie Mellon University
    Carnegie Mellon UniversityB.S., Biology, 1995 - 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - 2027
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Scholar Mayo Clinic Cardiovascular Board Review, 2013

Publications & Presentations

PubMed

Journal Articles

  • Evaluation of myocardial fibrosis by post gadolinium T1 measurement in patients with pulmonary hypertension  
    Kallianos K, Higgins C, Odrovas K, J Cardiovasc Magn Reson, 1/1/2015
  • Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus  
    Liu TC, Wang Y, Hallden G, Francis J, Lemoine NR, Kirn D., Gene Ther., 1/1/2005
  • Effects of febrile temperature on adenoviral infection and replication: implications for viral therapy of cancer  
    Thorne SH, Lee YL, Au T, Eng LF, Reid T., J Virol, 1/1/2005
  • Join now to see all

Abstracts/Posters

  • The Association Between Clinical and Echocardiographic Imaging Findings and T2 in End Stage Liver Disease
    Brown K, Mehta N, Rubin N, Foster E, Qasim A., American Heart Association, 1/1/2015
  • Evaluation of myocardial fibrosis by post gadolinium T1 measurement in patients with pulmonary hypertension
    Kallianos K, Higgins C, Ordovas K., Society for Cardiac Magnetic Resonance, Nice, 1/1/2015
  • Diagnostic Accuracy of a Smartphone based Six-Minute Walk Test
    Vittinghoff E, Sivaraman I, Marcus G, Olgin J, American Heart Association, 1/1/2014
  • Join now to see all

Lectures

  • Classifying lung cancer stage from health care claims with a clinical algorithm or a machine-learning approach. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • International Update on Fabry Disease and Provides Clinical Update
    International Update on Fabry Disease and Provides Clinical UpdateMay 30th, 2019

Professional Memberships